NCT00120692View on ClinicalTrials.gov

Treatment for Patients Suffering From Anemia Due to Chemotherapy

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2002

Study Completion Date

December 31, 2003

Conditions
Breast CancerAnemia
Interventions
DRUG

Darbepoetin Alfa

DRUG

Recombinant Human Erythropoietin

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY